570375-92-7

Basic information

• Product Name: (R)-4-Benzyl-3-[(2R,3R)-4-benzyloxy-3-hydroxy-2-(4-methoxy-phenyl)-butyryl]-oxazolidin-2-one
• Synonyms: (R)-4-Benzyl-3-[(2R,3R)-4-benzyloxy-3-hydroxy-2-(4-methoxy-phenyl)-butyryl]-oxazolidin-2-one
• CAS NO: 570375-92-7
• Molecular Weight: 475.541
• Mol File: 570375-92-7.mol

Chemical Properties

• CAS DataBase Reference: (R)-4-Benzyl-3-[(2R,3R)-4-benzyloxy-3-hydroxy-2-(4-methoxy-phenyl)-butyryl]-oxazolidin-2-one(CAS DataBase Reference)
• NIST Chemistry Reference: (R)-4-Benzyl-3-[(2R,3R)-4-benzyloxy-3-hydroxy-2-(4-methoxy-phenyl)-butyryl]-oxazolidin-2-one(570375-92-7)
• EPA Substance Registry System: (R)-4-Benzyl-3-[(2R,3R)-4-benzyloxy-3-hydroxy-2-(4-methoxy-phenyl)-butyryl]-oxazolidin-2-one(570375-92-7)

Safety Data

• Hazardous Substances Data: 570375-92-7(Hazardous Substances Data)

Upstream product

• 60656-87-3 benzyloxyacetoaldehyde 
• 143590-12-9 (R)-4-benzyl-3-(2-(4-methoxyphenyl)acetyl)oxazolidin-2-one 

Downstream Products

• 461644-54-2 (2R,3R)-4-benzyloxy-3-hydroxy-2-(4-methoxyphenyl)butanoic acid 

Relevant articles and documents

A new synthesis of cytoxazone and its diastereomers provides key initial SAR information

A short, enantioselective, and diastereoselective synthesis of cytoxazone, a Th2-selective immunomodulator from Streptomyces, is described. The route was readily adapted to the synthesis of the three other stereoisomers of natural cytoxazone. Evaluation of these compounds revealed that the stereochemical configuration of the oxazolidinone ring did not influence their biological activity.